Clinical Trial Update: Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on vasomotor reactivity in cerebral small vessel disease and a new approach to treat lacunar stroke, sponsored by Viatris/Pfizer U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Small Vessel Disease
• Lacunar Stroke
• Stroke

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Cerebrovascular Accident, Hypercholesterolemia | Phase 4 | Status: COMPLETED